ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 224 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.68 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $849,418 | -63.6% | 40,759 | -58.2% | 0.11% | -66.7% |
| Q2 2023 | $2,335,245 | -25.7% | 97,505 | -41.6% | 0.32% | -24.6% |
| Q1 2023 | $3,142,846 | +565.0% | 166,995 | +462.5% | 0.43% | +453.2% |
| Q4 2022 | $472,601 | +24.0% | 29,686 | +27.5% | 0.08% | +32.8% |
| Q3 2022 | $381,000 | -68.9% | 23,286 | -73.2% | 0.06% | -46.3% |
| Q2 2022 | $1,226,000 | -79.3% | 87,008 | -64.5% | 0.11% | -78.8% |
| Q1 2022 | $5,930,000 | +34.3% | 244,825 | +29.4% | 0.51% | +51.8% |
| Q4 2021 | $4,414,000 | +19.1% | 189,128 | -15.2% | 0.34% | +26.3% |
| Q3 2021 | $3,706,000 | +203.8% | 223,130 | +346.3% | 0.27% | +228.4% |
| Q2 2021 | $1,220,000 | -88.5% | 50,000 | -90.2% | 0.08% | -81.6% |
| Q3 2018 | $10,637,000 | +2.2% | 512,358 | -24.8% | 0.44% | +11.6% |
| Q2 2018 | $10,407,000 | -24.2% | 681,500 | +11.6% | 0.40% | -14.7% |
| Q1 2018 | $13,722,000 | +218.7% | 610,700 | +405.7% | 0.46% | -21.5% |
| Q4 2015 | $4,305,000 | +153.1% | 120,771 | +134.8% | 0.59% | +1452.6% |
| Q3 2015 | $1,701,000 | -73.3% | 51,431 | -66.1% | 0.04% | -77.1% |
| Q2 2015 | $6,360,000 | – | 151,852 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 432,317 | $11,154,000 | 4.70% |
| Baker Brothers Advisors | 41,910,704 | $1,081,296,000 | 4.69% |
| Palo Alto Investors LP | 2,337,877 | $60,317,000 | 3.44% |
| Birchview Capital, LP | 177,000 | $4,567,000 | 2.71% |
| Longitude (Cayman) Ltd. | 188,000 | $4,850,000 | 1.86% |
| GREAT POINT PARTNERS LLC | 311,217 | $8,029,000 | 1.66% |
| Avoro Capital Advisors LLC | 2,500,000 | $64,500,000 | 1.11% |
| PFM Health Sciences, LP | 1,302,129 | $33,595,000 | 1.03% |
| HealthCor Management, L.P. | 900,490 | $23,233,000 | 0.82% |
| Eversept Partners, LP | 420,000 | $10,836,000 | 0.82% |